Surprisingly, we did not observe a difference in GzmB or Prf1 expression between CD8+ T-cells isolated from MC38 tumors between groups, suggesting that impaired T-cell mediated anti-tumor immune responses are unlikely to explain the increased tumor burden observed in LysMCre/+;Mycfl/fl hosts. This evidence concerns the gene CD8A and neoplasm.